On July 11, 2025, the IMCAS China Conference was held in Shanghai. As a key participant, MEICET not only took part in the IMCAS exhibition but also hosted the Global Medical Aesthetics Experts Summit on AI and 3D Facial Imaging Clinical Applications at the main venue of the event. The summit featured special guest speakers Dr. Tingsong Lim, Professor Xia Wenhua, Dr. Edmond Lau,
Professor Jin Chenglong, four leading domestic and international medical aesthetics experts, to share their clinical diagnostic and therapeutic experiences with attendees. They provided an in-depth analysis of the application of AI+3D facial imaging technology in clinical diagnostics and treatment, as well as the latest international aesthetic concepts, jointly exploring the boundless possibilities of AI+3D facial imaging technology in clinical diagnostics and treatment. They also innovated the imaging detection functions of Meicet, committed to providing high-quality, high-intelligence 3D imaging technology for global medical aesthetics diagnostics and treatment.
Rooted in China · Building a Global Brand
Mr. Shen Fabin, Founder and CEO of MEICET & ISEMECO, has deeply focused on brand strategy and global expansion, stating that branding is the intrinsic foundation of globalization. Only by creating a brand with strong competitive strength can one stand firm in global competition.
Since 2011, we have consistently collaborated with renowned domestic and international institutions and experts, listening to industry insights, introducing cutting-edge technologies, and maintaining our core technological capabilities. Through continuous innovation, we have become a leading brand in the domestic market. In 2018, we undertook two major transformations: first, establishing ISEMECO, and second, determining our brand’s global expansion strategy. We aim to introduce mature
products and concepts to the global market while absorbing international experience to optimize our own products. Today, we have established a comprehensive ecosystem covering over 60 countries and regions, encompassing “testing, diagnosis, products, and services.” Looking ahead, while remaining rooted in China, we are committed to becoming a leading global provider of digital and intelligent solutions for the beauty industry.
Laying the foundation for academic clinical practice
The practical application of technology cannot be separated from clinical practice. This summit brought together medical aesthetics experts who, with their rich clinical experience, profound academic knowledge, and vivid presentation styles, explained complex professional knowledge in an easy-to-understand manner, allowing participants to immerse themselves in the content and gain a lot.
Dr. Tingsong Lim
Drawing on extensive clinical experience, Dr. Lim addresses the challenges of facial fillers, focusing on the pathophysiological mechanisms and clinical implications of overfilling syndrome and facial interstitial fibrosis. Combining his clinical expertise, he develops innovative strategies for precise diagnosis and treatment, personalized therapy, and the prevention of complications.
Professor Xia Wenhua
Deeply analyzes the clinical application value of AI+3D facial imaging technology. In clinical practice, imaging technology can assist in precise preoperative planning, real-time navigation during surgery, and postoperative effect evaluation, improving the accuracy of diagnosis and treatment, providing visual support for personalized medical beauty solutions, and bringing new ideas to the development of the medical beauty industry.
Dr. Edmond Lau
Connecting international medical aesthetics treatment fields, medical aesthetics knows no borders. Sharing clinical application experiences with participants, based on cross-polarized light digital imaging, accurately presenting the distribution of blood vessels and inflammation in rosacea, forming a comprehensive strategy from diagnosis to treatment, and enhancing clinical treatment outcomes.
Professor Jin Chenglong
Focusing on the diagnosis and treatment of melasma, he uses advanced imaging technology to accurately analyze its skin lesions and pigment distribution. Based on this, he proposes targeted clinical treatment approaches to achieve seamless integration between accurate diagnosis and effective treatment, thereby improving the accuracy of melasma diagnosis and providing the medical aesthetics industry with comprehensive clinical insights into melasma treatment.
Unlocking the New Potential in Clinical Aesthetic Medicine
This summit is not only a feast of technology but also a platform for in-depth exchange of medical expertise.
The roundtable forum themed “AI + 3D Imaging Reshaping the Future of Medical Aesthetics” brought the summit to a climax. Dr. Tingsong Lim, Professor Xia Wenhua, Dr. Edmond Lau, Professor Jin Chenglong, and Mr. Shen gathered together, sharing their perspectives and engaging in intellectual exchanges, exploring the impact of skin testing in clinical diagnostics from various angles.
They addressed questions from attendees regarding safety, efficacy, and feasibility, driving the medical aesthetics industry toward standardized development and guiding traditional empirical medicine toward evidence-based medicine.
Pioneering a New Ecosystem for Global Medical Aesthetics Treatment
This is a collision and fusion of cutting-edge technology and medical skills. MEICET & ISEMECO has been deeply involved in the medical aesthetics industry for 14 years. With the arrival of the new era of digitalization and intelligence in medical aesthetics 3.0, we believe that medical skills know no borders and technology has no limits. Guided by brand globalization, we will continue to improve the technological content and quality of our products, as well as deepen our brand service philosophy, so that Chinese brands can occupy a place in the international market.
Post time: Jul-15-2025
